Veracyte EBITDA 2012-2025 | VCYT
Veracyte ebitda from 2012 to 2025. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.
| Veracyte Annual EBITDA (Millions of US $) |
|
|---|---|
| 2024 | $40 |
| 2023 | $-59 |
| 2022 | $-15 |
| 2021 | $-62 |
| 2020 | $-27 |
| 2019 | $-11 |
| 2018 | $-18 |
| 2017 | $-22 |
| 2016 | $-26 |
| 2015 | $-33 |
| 2014 | $-30 |
| 2013 | $-25 |
| 2012 | $-21 |
| 2011 | $-15 |
| Veracyte Quarterly EBITDA (Millions of US $) |
|
|---|---|
| 2025-03-31 | $8 |
| 2024-12-31 | $10 |
| 2024-09-30 | $18 |
| 2024-06-30 | $10 |
| 2024-03-31 | $1 |
| 2023-12-31 | $-29 |
| 2023-09-30 | $-24 |
| 2023-06-30 | $-1 |
| 2023-03-31 | $-4 |
| 2022-12-31 | $1 |
| 2022-09-30 | $-3 |
| 2022-06-30 | $-4 |
| 2022-03-31 | $-9 |
| 2021-12-31 | $-6 |
| 2021-09-30 | $-11 |
| 2021-06-30 | $-3 |
| 2021-03-31 | $-43 |
| 2020-12-31 | $-6 |
| 2020-09-30 | $-2 |
| 2020-06-30 | $-9 |
| 2020-03-31 | $-10 |
| 2019-12-31 | $-7 |
| 2019-09-30 | $-1 |
| 2019-06-30 | $-2 |
| 2019-03-31 | $-1 |
| 2018-12-31 | $-2 |
| 2018-09-30 | $-3 |
| 2018-06-30 | $-5 |
| 2018-03-31 | $-8 |
| 2017-12-31 | $-5 |
| 2017-09-30 | $-5 |
| 2017-06-30 | $-6 |
| 2017-03-31 | $-7 |
| 2016-12-31 | $-3 |
| 2016-09-30 | $-4 |
| 2016-06-30 | $-10 |
| 2016-03-31 | $-9 |
| 2015-12-31 | $-8 |
| 2015-09-30 | $-9 |
| 2015-06-30 | $-9 |
| 2015-03-31 | $-8 |
| 2014-12-31 | $-8 |
| 2014-09-30 | $-8 |
| 2014-06-30 | $-7 |
| 2014-03-31 | $-7 |
| 2013-12-31 | $-6 |
| 2013-09-30 | $-6 |
| 2013-06-30 | $-6 |
| 2013-03-31 | $-6 |
| 2012-12-31 | |
| 2012-09-30 | $-5 |
| 2012-06-30 | |
| 2011-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $2.071B | $0.446B |
| Veracyte, Inc. is a diagnostics company. It is focused on discovering, developing and commercializing molecular cytology solutions. The Company provides Afirma Thyroid FNA Analysis, which helps physicians in reducing unnecessary diagnostic surgeries for patients with thyroid nodules. Veracyte is also developing Afirma Malignant GEC test. It serves endocrinologists, radiologists, and head and neck specialists. Veracyte, Inc. is headquartered in South San Francisco, California. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Intuitive Surgical (ISRG) | United States | $183.575B | 80.41 |
| Thermo Fisher Scientific (TMO) | United States | $152.039B | 18.39 |
| Edwards Lifesciences (EW) | United States | $44.083B | 28.90 |
| Alcon (ALC) | Switzerland | $42.518B | 28.73 |
| IDEXX Laboratories (IDXX) | United States | $42.037B | 48.31 |
| DexCom (DXCM) | United States | $32.149B | 49.69 |
| IQVIA Holdings (IQV) | United States | $27.142B | 15.20 |
| Mettler-Toledo (MTD) | United States | $24.013B | 28.56 |
| STERIS (STE) | Ireland | $23.741B | 26.15 |
| Waters (WAT) | United States | $20.370B | 28.74 |
| SONOVA HOLDING (SONVY) | Switzerland | $18.723B | 0.00 |
| Hologic (HOLX) | United States | $14.429B | 15.68 |
| Sysmex ADR (SSMXY) | Japan | $10.852B | 30.79 |
| Penumbra (PEN) | United States | $9.933B | 77.96 |
| Masimo (MASI) | United States | $8.740B | 32.24 |
| Globus Medical (GMED) | United States | $7.974B | 19.00 |
| Glaukos (GKOS) | United States | $5.577B | 0.00 |
| Teleflex (TFX) | United States | $5.300B | 8.75 |
| TransMedics (TMDX) | United States | $4.833B | 105.06 |
| Integer Holdings (ITGR) | United States | $4.128B | 21.63 |
| PROCEPT BioRobotics (PRCT) | United States | $3.355B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.495B | 14.86 |
| Nihon Kohden (NHNKY) | Japan | $2.264B | 25.96 |
| Elekta AB (EKTAY) | Sweden | $1.901B | 17.09 |
| Alphatec Holdings (ATEC) | United States | $1.617B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.383B | 0.00 |
| Artivion (AORT) | United States | $1.206B | 113.00 |
| Pulse Biosciences (PLSE) | United States | $1.061B | 0.00 |
| OPKO Health (OPK) | United States | $1.055B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $0.945B | 5.02 |
| Beta Bionics (BBNX) | United States | $0.828B | 0.00 |
| SiBone (SIBN) | United States | $0.742B | 0.00 |
| IRadimed (IRMD) | United States | $0.740B | 37.53 |
| RxSight (RXST) | United States | $0.577B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.560B | 8.71 |
| Delcath Systems (DCTH) | United States | $0.534B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.530B | 12.42 |
| OrthoPediatrics (KIDS) | United States | $0.514B | 0.00 |
| AxoGen (AXGN) | United States | $0.444B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.433B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.431B | 0.00 |
| NeuroPace (NPCE) | United States | $0.363B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.360B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.357B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.330B | 8.78 |
| ClearPoint Neuro (CLPT) | United States | $0.323B | 0.00 |
| 908 Devices (MASS) | United States | $0.262B | 0.00 |
| Neuronetics (STIM) | United States | $0.249B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.229B | 13.86 |
| Sight Sciences (SGHT) | United States | $0.214B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.213B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.183B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.174B | 0.00 |
| Inogen (INGN) | United States | $0.168B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.158B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.156B | 0.00 |
| CVRx (CVRX) | United States | $0.153B | 0.00 |
| LENSAR (LNSR) | United States | $0.147B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.140B | 0.00 |
| Accuray (ARAY) | United States | $0.126B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.107B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.095B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.085B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.079B | 48.10 |
| EnVVeno Medical (NVNO) | United States | $0.076B | 0.00 |
| InspireMD (NSPR) | United States | $0.071B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.064B | 0.00 |
| Hyperfine (HYPR) | United States | $0.056B | 0.00 |
| Spectral AI (MDAI) | United States | $0.050B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.047B | 0.00 |
| Precision Optics (POCI) | United States | $0.037B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.036B | 0.00 | |
| DarioHealth (DRIO) | United States | $0.030B | 0.00 |
| Envoy Medical (COCH) | United States | $0.029B | 0.00 |
| NexGel (NXGL) | United States | $0.020B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.017B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.012B | 0.00 |
| PAVmed (PAVM) | United States | $0.011B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.009B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.009B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.008B | 0.00 |
| Tenon Medical (TNON) | United States | $0.007B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.006B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.004B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.004B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Nuwellis (NUWE) | United States | $0.001B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.001B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 16.35 |